Announcements  

Announcements
 
 BMGF – Gates Foundation  [to 16 September 2017]
http://www.gatesfoundation.org/Media-Center/Press-Releases
SEPTEMBER 13, 2017
New Gates Foundation Report Highlights Remarkable Progress Against Global Poverty and Disease, Warns Future Progress in Jeopardy
Bill and Melinda Gates Call for Strong Leadership to Address “Solvable Human Misery”
[See Week in Review above for more detail]
 
CEPI – Coalition for Epidemic Preparedness Innovations  [to 16 September 2017]
http://cepi.net/
[Undated]
Board member advert
CEPI is now looking for visionary leaders to serve on its new permanent Board and help guide the coalition through its next phase of growth, maximising the positive impact that CEPI can make in the years ahead.
To express your interest in being a member of CEPI’s board, or to nominate an individual you believe to be an exceptional candidate, please email board@cepi.net by October 1, 2017, providing a CV where possible.
PDF FORMAT – 50KB  Download

European Medicines Agency  [to 16 September 2017]
http://www.ema.europa.eu/ema/
15/09/2017
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11 to 14 September 2017
Thirteen medicines recommended for approval, including one orphan medicine

12/09/2017
Raising awareness of the perils of antimicrobial resistance
EMA to host a meeting with key stakeholders on the work of international health authorities and how to optimise collaboration …
 
FDA [to 16 September 2017]
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
What’s New in Biologics
Influenza Virus Vaccine for the 2017-2018 Season
Updated: 9/14/2017
 
Fondation Merieux  [to 16 September 2017]
http://www.fondation-merieux.org/
September 14, 2017
The Mérieux Fondation is celebrating 50 years of fighting infectious diseases in developing countries
Les Pensiéres Center for Global Health, Veyrier-du-Lac (France)
[See Milestones above for more detail
 
Global Fund [to 16 September 2017]
http://www.theglobalfund.org/en/news/?topic=&type=NEWS;&country=
News
22 Million Lives Saved
13 September 2017
Programs supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria have saved 22 million lives, according to a report released today. The report also shows significant increases in the number of people receiving treatment for HIV, diagnosis and treatment for TB and having an insecticide treated net to prevent malaria…
The Global Fund Results Report 2017, with cumulative results through the end of 2016, shows a decline of one-third in the number of people dying from AIDS, TB and malaria in the countries where the Global Fund invests…
Programs supported by the Global Fund, which are designed and implemented by local experts and communities affected by the diseases, provided 11 million people with antiretroviral therapy for HIV – more than half the total number of people on treatment worldwide.
Global Fund-supported programs have provided 17.4 million people with testing and treatment for TB, and 795 million mosquito nets to prevent malaria. As a result of prevention and control interventions in more than 100 countries, the Global Fund’s target of averting 140-180 million infections by the end of 2016 was met in 2015…
Report pdf [52 pages]:
https://www.theglobalfund.org/media/6773/corporate_2017resultsreport_report_en.pdf
 
NIH  [to 16 September 2017]
http://www.nih.gov/news-events/news-releases
September 12, 2017
NIH awards $15 million to support development of 3-D human tissue models
“Tissue chips” to be engineered to model disease and test drug efficacy prior to clinical trials.

Dr. James Ostell named Director of the National Center for Biotechnology Information
September 11, 2017 — NCBI maintains biomedical databases, including PubMed, GenBank, BLAST, Entrez, RefSeq, dbSNP, PubMed Central and dbGaP.
 
PATH  [to 16 September 2017]
http://www.path.org/news/index.php
Announcement | September 14, 2017
PATH joins world leaders in New York City this week to advocate for innovation to create a healthier, more secure world

Announcement | September 11, 2017
PATH announces new collaboration to advance maternal immunization in low- and middle-income countries
[See Milestones above for more details]

UNAIDS [to 16 September 2017]
http://www.unaids.org/en
Update
Thailand launches new national strategy to end the AIDS epidemic by 2030
15 September 2017
The Ministry of Public Health of Thailand has launched its new 2017–2030 National AIDS Strategy, which provides a road map for ending the AIDS epidemic as a public health threat in Thailand by 2030. Narong Pipatanasai, Deputy Prime Minister and Chair of the National AIDS Committee, led the launch at the Government Complex in Bangkok, Thailand, on 13 September.
The 13-year plan adapts the latest global commitments to Thailand, ensuring an effective, cost-efficient and high-impact HIV response. A recent UNAIDS report on the global AIDS epidemic finds that annual new HIV infections dropped by 50% in Thailand between 2010 and 2016, the steepest decline for any country in the Asia and the Pacific region…

Update
UNAIDS and Malaysia launch joint data web platform
14 September 2017
UNAIDS and the Ministry of Health of Malaysia have launched a joint web platform that aims to strengthen the generation of strategic information and the use of national, subnational and key population data for evidence-informed programming.
The platform, which is hosted and supported by the UNAIDS regional data hub, was launched by Noor Hisham Abdullah, Director-General of Malaysia’s Ministry of Health, and Eamonn Murphy, Director of the UNAIDS Regional Support Team for Asia and the Pacific, at the 5th Asia Pacific Conference on Public Health, which ended on 13 September in Kuching, Malaysia…

Update
Metro Manila city leaders commit to intensifying HIV response
11 September 2017
Mayors and other city leaders from the 17 cities that make up the National Capital Region in the Philippines pledged to make the HIV epidemic a public health emergency requiring multisectoral strategies and a full provision of resources. The city representatives recently signed a city HIV resolution during a dinner meeting in Manila hosted by the Secretary of the Department of Health, Paulyn Jean Rosell-Ubial…
 
Wellcome Trust  [to 16 September 2017]
https://wellcome.ac.uk/news
News / Published: 12 September 2017
European foundations unite to tackle global challenges
Three of Europe’s biggest philanthropic foundations have joined together to award €5m to tackle some of the most pressing global challenges of our time.
Wellcome Trust, Volkswagen Stiftung and Riksbankens Jubileumsfond have funded six research groups as part of the Europe and Global Challenges Initiative. The projects range from understanding how to best protect and integrate Syrian refugees, to strengthening climate action in the global south. Each partner will fund two projects directly.
 
::::::
 
 
DCVMN – Developing Country Vaccine Manufacturers Network  [to 16 September 2017]
http://www.dcvmn.org/
25 September 2017 to 28 September 2017
DCVMN Annual General Meeting
Seoul / Korea
Download the Agenda
 
 
Industry Watch
:: FDA Advisory Committee votes unanimously for Shingrix (HZ/su) in the US for prevention of herpes zoster (shingles) in adults ages 50 and over
LONDON, Sept. 13, 2017 /PRNewswire/ — GlaxoSmithKline plc announced today that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the US Food and Drug Administration (FDA) voted unanimously that the data support the efficacy and safety of Shingrix, for the prevention of herpes zoster (shingles) in adults ages 50 and over. FDA Advisory Committees provide non-binding recommendations for consideration by the FDA, with the final decision on approval made by the FDA.
Dr. Emmanuel Hanon, Senior Vice President and Head of Vaccines R&D for GSK said: “Shingles is a painful and potentially serious condition. The risk of developing shingles increases with age and it is estimated that up to one in three people in the United States will develop shingles. Today’s vote brings us one step closer to approval of Shingrix, which is specifically designed to overcome age-related weakening of the immune system.”
The Biologics License Application (BLA) was submitted to the FDA in October 2016…